Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H2O2‑treated human pulmonary fibroblasts
- Authors:
- Published online on: February 28, 2013 https://doi.org/10.3892/ol.2013.1216
- Pages: 1633-1638
Abstract
Introduction
Reactive oxygen species (ROS) are mainly comprised of hydrogen peroxide (H2O2), superoxide anions (O2•−) and hydroxyl radicals (•OH), which affect numerous cellular processes, including metabolism, differentiation and cell proliferation and death, by regulating critical signaling pathways (1,2). Unlike other ROS, H2O2 is capable of freely diffusing through biological membranes the width of several cells prior to reacting with specific molecular targets. ROS are mostly generated during the process of mitochondrial respiration and by specific oxidases, including nicotine adenine diphosphate (NADPH) oxidase and xanthine oxidase (3). The main metabolic pathways use superoxide dismutases, which metabolize O2•− to H2O2(4). Further metabolism by catalase or glutathione (GSH) peroxidase yields O2 and H2O (5). Oxidative stress occurs through an increase in ROS levels and/or a decrease in cellular antioxidants, and leads to cell death (6–8). Exogenous H2O2 is frequently used as a representative ROS in modeling and inducing oxidative stress.
Three major groups of mitogen-activated protein kinases (MAPKs) exist: extracellular signal-regulated kinase (ERK1/2), c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) and p38 (9). MAPKs are involved in crucial signaling pathways in cell proliferation, differentiation and cell death in response to various signals produced by growth factors, hormones and cytokines, as well as genotoxic and oxidative stressors (9,10). Each MAPK pathway has comparatively varied upstream activators and unambiguous substrates (11). Abundant evidence has demonstrated that JNK and p38 are activated by ROS or mild oxidative shifts in the intracellular thiol/disulfide redox state, initiating processes associated with apoptosis (12,13). ROS provoke ERK phosphorylation and also stimulate the ERK pathway (14). In the majority of instances, ERK activation has a pro-survival effect rather than a pro-apoptotic effect (15). In addition, MAPK pathways are also activated by the direct inhibition of MAPK phosphatases by the ROS. Since the differing and opposing effects on MAPKs are caused by various ROS in the cells, the correlation between ROS and MAPKs requires further clarification, particularly with regard to the signaling associated with cell survival and death.
Cultured normal human cells are invaluable biological models for mechanistic studies of oxidative stress. H2O2-induced cytotoxicity in normal fibroblast cells in vitro may be of interest in toxicological research with regard to the toxic potential of exogenous H2O2 in human pulmonary fibroblasts (HPFs) since HPFs are closely involved in lung inflammation, fibrosis and cancer. However, the toxicological mechanism of the effects of exogenous H2O2 on normal HPFs remains unknown with regard to MAPKs. The present study investigated the effects of the well-known antioxidants N-acetyl cysteine (NAC) and propyl gallate (PG), as well as the MAPK inhibitors, on H2O2-treated HPFs in relation to cell growth and death and the ROS and GSH levels.
Materials and methods
Cell culture
HPFs purchased from PromoCell GmbH (Heidelberg, Germany) were maintained in a humidified incubator at 37°C with 5% CO2. The HPFs were cultured in RPMI-1640 supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) penicillin-streptomycin (GIBCO BRL, Grand Island, NY, USA). The HPFs were grown in 100-mm plastic tissue culture dishes (Nunc, Roskilde, Denmark) and harvested with trypsin-EDTA solution while in the logarithmic growth phase. The HPFs between passages four and eight were used. The study was approved by the Ethics Committee of Chonbuk National University, Jeonju, Republic of Korea.
Reagents
H2O2, NAC and PG were purchased from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). The NAC was dissolved in buffer [20 mM HEPES (pH 7.0)], while the PG was dissolved in ethanol at 200 mM as a stock solution. JNK inhibitors (SP600125), MEK inhibitors (PD98059) and p38 inhibitors (SB203580) were purchased from Calbiochem (San Diego, CA, USA). All the inhibitors were dissolved in DMSO at 10 mM as stock solutions. The HPFs were pretreated with 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 1 h prior to treatment with H2O2. Ethanol (0.2%) and DMSO (0.2%) were used as control vehicles and did not affect cell growth or death.
Cell growth and cell number assays
The changes in cell growth in the HPFs were indirectly determined by measuring the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich Chemical Company) dye absorbance. In brief, 4×104 cells per well were seeded in 96-well microtiter plates (Nunc). Following exposure to 50 μM H2O2, with or without 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 24 h, 20 μl MTT solution (2 mg/ml in PBS) was added to each well of the 96-well plates. The plates were incubated for an additional 4 h at 37°C. The media in the plates were withdrawn by pipetting and 200 μl DMSO was added to each well to solubilize the formazan crystals. The optical density was measured at 570 nm using a microplate reader (Synergy™ 2; BioTek Instruments Inc., Winooski, VT, USA).
Annexin V-fluorescein isothiocyanate (FITC) staining for cell death detection
Apoptosis was determined by staining cells with annexin (Invitrogen Corporation, Camarillo, CA, USA; Ex/Em = 488 nm/519 nm). In brief, 1×106 cells were incubated in a 60-mm culture dish (Nunc) with 50 μM H2O2, with or without 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 24 h. The cells were washed twice with cold PBS, then resuspended in 500 μl binding buffer (10 mM HEPES/NaOH, pH 7.4; 140 mM NaCl; 2.5 mM CaCl2) at a concentration of 1×106 cells/ml. Annexin V-FITC (5 μl) was then added to the cells, which were analyzed with a FACStar flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).
Measurement of mitochondrial membrane potential (MMP; Δψm)
MMP (Δψm) levels were measured with a rhodamine 123 fluorescent dye (Sigma-Aldrich Chemical Company; Ex/Em = 485 nm/ 535 nm). In brief, 1×106 cells were incubated in a 60-mm culture dish (Nunc) with 50 μM H2O2, with or without 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 24 h. The cells were washed twice with PBS and incubated with the rhodamine 123 (0.1 μg/ml) at 37°C for 30 min. Rhodamine 123 staining intensity was determined with a FACStar flow cytometer (Becton Dickinson). Rhodamine 123-negative cells indicated the loss of MMP (Δψm) in cells.
Detection of intracellular ROS levels
Intracellular ROS such as H2O2, •OH and ONOO• were detected using an oxidation-sensitive fluorescent probe dye, 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA; Ex/Em = 495 nm/529 nm; Invitrogen Molecular Probes, Eugene, OR, USA). H2DCFDA is poorly selective for O2•−. By contrast, dihydroethidium (DHE; Ex/Em = 518 nm/605 nm; Invitrogen Molecular Probes) is highly selective for O2•− among all the ROS. In brief, 1×106 cells were incubated in a 60-mm culture dish (Nunc) with 50 μM H2O2, with or without 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 24 h. The cells were then incubated with 20 μM H2DCFDA or dihydroethidium (DHE) at 37°C for 30 min. The fluorescence of DCF and DHE was detected using a FACStar flow cytometer (Becton Dickinson). The ROS and O2•− levels were expressed as the mean fluorescence intensity (MFI), which was calculated by CellQuest software (Becton Dickinson).
Detection of the intracellular GSH
The cellular GSH levels were analyzed using a 5-chloromethylfluorescein diacetate dye (CMFDA, Ex/Em = 522 nm/595 nm; Invitrogen Molecular Probes). In brief, 1×106 cells were incubated in a 60-mm culture dish (Nunc) with 50 μM H2O2, with or without 2 mM NAC, 400 μM PG or 10 μM MAPK inhibitors for 24 h. The cells were then incubated with 5 μM CMFDA at 37°C for 30 min. The CMF fluorescence intensity was determined using a FACStar flow cytometer (Becton Dickinson). CMF-negative (GSH-depleted) cells were expressed as the percent of CMF− cells.
Statistical analysis
The results represent the mean of at least two independent experiments (mean ± SD). The data were analyzed using Instat software (GraphPad Prism4; GraphPad Software, San Diego, CA, USA). The Student’s t-test and a one-way analysis of variance (ANOVA) with post hoc analysis, using Tukey’s multiple comparison, were applied to the parametric data. P<0.05 was considered to indicate a statistically significant difference.
Results
Effects of NAC and PG on cell growth and death and MMP (Δψm) levels in H2O2-treated HPFs
The effects of NAC and PG on cell growth and death and MMP (Δψm) levels were investigated in H2O2-treated HPFs at 24 h using MTT assays. A concentration of 50 μM H2O2 was used as an optimal dose in this experiment; this inhibited the growth of the HPFs by ∼45% in 24 h (Fig. 1A). NAC and PG significantly reduced the growth inhibition caused by H2O2, with PG showing a more marked effect (Fig. 1A). H2O2 increased the percentage of annexin V-FITC stained cells among the HPFs, indirectly indicating that the HPF cell death caused by H2O2 occurred via apoptosis (Fig. 1B). NAC and PG significantly reduced the number of annexin V-FITC-positive cells in the H2O2-treated HPFs, while PG completely prevented the HPF cell death caused by H2O2 (Fig. 1B). Notably, PG alone increased the number of annexin V-FITC-positive cells among the control HPFs (Fig. 1B). Since cell death is closely associated with the collapse of MMP (Δψm) (16), the effect of H2O2 on MMP (Δψm) in the HPFs was assessed using a rhodamine 123 dye. Treatment with 50 μM H2O2 significantly induced the loss of MMP (Δψm) in the HPFs (Fig. 1C). NAC and PG attenuated the loss of MMP (Δψm) caused by H2O2, while PG totally prevented this loss (Fig. 1C). Similar to the number of annexin V-FITC-positive cells, PG also increased the number of cells that lost MMP (Δψm) among the control HPFs (Fig. 1C).
Effects of NAC and PG on intracellular ROS and GSH levels in H2O2-treated HPFs
H2DCFDA and DHE dyes were used to assess intracellular ROS levels in the H2O2-treated HPFs. As shown in Fig. 2A, the levels of ROS (DCF), such as H2O2, were increased in the HPFs treated with 50 μM at 24 h. NAC significantly suppressed the increased ROS levels in the H2O2-treated HPFs, whereas PG enhanced the increase in ROS levels caused by H2O2 (Fig. 2A). Moreover, PG alone markedly increased the ROS (DCF) levels in the control HPFs (Fig. 2A). When the intracellular O2•− levels were assessed in the H2O2-treated HPFs, the level of DHE fluorescence dye, which specifically indicates O2•− accumulation in cells, was increased at 24 h (Fig. 2B). While NAC did not alter the O2•− level in the H2O2-treated HPFs, PG entirely attenuated the increase in these cells (Fig. 2B). However, PG alone increased the O2•− level in the control HPFs (Fig. 2B). When the intracellular GSH levels were measured in the H2O2-treated HPFs using a CMFDA dye, 50 μM H2O2 was shown to increase the number of GSH-depleted cells in the HPFs at 24 h (Fig. 2C). NAC and PG significantly reduced the number of GSH-depleted cells in the H2O2-treated HPFs, while PG completely prevented the GSH depletion (Fig. 2C).
Effects of MAPK inhibitors on cell growth and death and MMP (Δψm) levels in H2O2-treated HPFs
The effect of the MAPK inhibitors on cell growth and death and MMP (Δψm) levels in the H2O2-treated HPFs was evaluated. Based on previous studies (17,18), 10 μM of each MAPK inhibitor was used as an optimal dose in the present study. None of the MAPK inhibitors affected the growth inhibition caused by H2O2 (Fig. 3A). p38 inhibitor alone increased the growth of control HPFs (Fig. 3A). Additionally, none of the MAPK inhibitors affected the number of annexin V-stained cells among the H2O2-treated or -untreated HPFs (Fig. 3B). All the MAPK inhibitors appeared to enhance the loss of MMP (Δψm) in the H2O2-treated HPFs (Fig. 3C).
Effects of MAPK inhibitors on intracellular ROS and GSH levels in H2O2-treated HPFs
The changes in intracellular ROS levels in the H2O2 and/or each MAPK inhibitor-treated HPF were assessed. As shown in Fig. 4A, the MEK and JNK inhibitors only marginally enhanced the ROS levels in the H2O2-treated HPFs, whereas the p38 inhibitor appeared to decrease the ROS levels (Fig. 4A). In addition, all the MAPK inhibitors marginally intensified the O2•− level increase caused by H2O2 (Fig. 4B). The p38 inhibitor alone increased the ROS levels, including the O2•− level, in the HPF control cells (Fig. 4A and B). Moreover, none of the MAPK inhibitors affected the number of GSH-depleted cells in the H2O2-treated or untreated HPFs (Fig. 4C).
Discussion
HPFs are pathophysiologically involved in lung inflammation, fibrosis and cancer since these cells synthesize extracellular matrix and collagen to maintain the structural and functional integrity of the lung. The present study focused on elucidating the cytotoxic effect of exogenous H2O2 on cell growth and death in normal HPFs, in relation to ROS and MAPKs. Treatment with 50 μM H2O2 inhibited the growth of HPFs by ∼45% in 24 h. H2O2 increased the number of annexin V-FITC-positive cells among the HPFs, indicating that H2O2-induced HPF cell death occurred via apoptosis. An increase in caspase-3 activity was also observed in the H2O2-treated HPFs (data not shown). In addition, H2O2 triggered the loss of MMP (Δψm) in the HPFs. The level cells with MMP (Δψm) loss appeared to be similar to that of the annexin V stained cells, suggesting that cell death caused by H2O2 was markedly correlated with the collapse of MMP (Δψm).
ROS toxicity in cells is generally mediated by •OH (19). H2O2 and O2•− are the main ROS involved in the cell signaling pathways. According to the present results, the ROS levels, including those of O2•−, were significantly increased in the HPFs treated with H2O2. Since 50 μM H2O2 induced cell death and MMP (Δψm) loss in the HPFs, it is possible that exogenous H2O2 generates O2•− by damaging the mitochondria and that H2O2 and O2•− may be efficiently converted into toxic •OH via the Fenton reaction, resulting in the death of the HPFs. It is also possible that H2O2 activates oxidases, such as NADPH oxidase and xanthine oxidase, in HPFs to generate O2•−. In th epresent study, NAC attenuated the growth inhibition and cell death of the H2O2-treated HPFs and also significantly attenuated the MMP (Δψm) loss in these cells. NAC markedly decreased the ROS (DCF) levels in the H2O2-treated HPFs. However, NAC did not reduce the increased O2•− (DHE) level caused by H2O2, suggesting that NAC did not block the O2•− generation pathway induced by exogenous H2O2. In addition, the O2•− level in the HPFs co-treated with H2O2 and NAC did not appear to be correlated with HPF cell death.
PG, as a synthetic antioxidant, exerts a variety of effects on tissues and cells. For example, PG is an efficient protector of liver cells against lipid peroxidation by oxygen radicals (20). By contrast, PG has pro-oxidant properties (21,22). The anti-oxidative and cytoprotective properties of PG may change to pro-oxidative, cytotoxic and genotoxic properties in the presence of Cu(II) (23). The present results demonstrated that PG alone marginally inhibited the growth of the HPFs and induced cell death accompanied by the loss of MMP (Δψm). In addition, PG increased the ROS levels, including those of O2•−, in the HPFs. Thus, it is possible that PG, as a pro-oxidant, is able to directly generate mitochondrial O2•− in the HPFs by impairing mitochondrial function, consequently leading to HPF cell death via oxidative stress. Similarly, it has been reported that PG causes cytotoxic effects in isolated rat hepatocytes by causing mitochondrial damage (24) and that it also increases mitochondrial O2•− levels in HeLa cells (25). Notably, PG markedly attenuated the growth inhibition and cell death in the H2O2-treated HPFs and also prevented MMP (Δψm) loss in these cells. Moreover, PG completely abrogated the O2•− (DHE) level increase caused by H2O2. Therefore, PG appeared to protect the HPFs against exogenous H2O2 by protecting the mitochondria. However, PG increased the ROS (DCF) levels in the H2O2-treated HPFs. Numerous studies, including the present study, support the hypothesis that PG has a role as an antioxidant (20,26,27) or as a pro-oxidant (21,22), depending on various conditions, such as the cell culture media, the co-treated drugs and the cell types. PG is likely to have differing effects on the levels of the different ROS in the cells. Further studies are required to elucidate the exact roles of the types of ROS in PG-treated HPFs.
In the present study, the MEK inhibitor, which is likely to inactivate ERK, did not affect growth inhibition or cell death in the H2O2-treated HPFs. Thus, H2O2 did not directly regulate the signaling associated with ERK in the HPFs to induce their growth inhibition and death. In addition, the JNK and p38 MAPKs, which are generally associated with cell death (12,13), were not likely to be affected by H2O2 in the HPFs since none of the inhibitors affected the growth inhibition and cell death caused by H2O2. The p38 inhibitor alone increased the growth of the control HPFs, suggesting that p38 signaling is involved in the basal level of HPF growth. With regard to MMP (Δψm), all the MAPK inhibitors marginally increased the loss of MMP (Δψm) in the H2O2-treated HPFs, indicating that the dysregulation of these MAPK signalings enhanced the loss in these cells. Moreover, the MAPK inhibitors marginally, but not significantly, affected the ROS levels, including that of O2•−, in the H2O2-treated HPFs. The p38 inhibitor increased the ROS levels in the HPF control cells regardless of the level of cell death, while the other inhibitors mildly affected the ROS levels, including that of O2•−. Thus, the MAPK signalling in the H2O2-treated and -untreated HPFs did not meaningfully change the redox state to affect HPF death.
GSH is a key cellular non-protein antioxidant, which reduces H2O2 to H2O using GSH peroxidase (28). The intra-cellular GSH content has a significant effect on anticancer drug-induced apoptosis, indicating that apoptotic effects are inversely proportional to the GSH content (29,30). Similarly, in the present study, H2O2 increased the number of GSH-depleted cells in the HPFs. NAC and PG demonstrated anti-apoptotic effects on the H2O2-treated HPFs, significantly suppressing the GSH depletion in these cells. In addition, none of the MAPK inhibitors affected the GSH depletion in the H2O2-treated HPFs. Therefore, the intracellular GSH content appears to be a decisive factor in HPF cell death. However, PG alone induced cell death in the HPF control cells but it did not significantly induce GSH depletion,, suggesting that PG-induced HPF cell death is not highly associated with changes in the GSH level.
In conclusion, H2O2 induced growth inhibition and death in the HPFs via GSH depletion. NAC and PG attenuated H2O2-induced HPF cell growth inhibition and death, but each antioxidant affected the ROS levels, including that of O2•−, differently in the H2O2-treated and -untreated HPFs. Treatment with MAPK inhibitors did not affect cell death or the ROS levels in the H2O2-treated HPFs. The present data provide useful information concerning the toxicological effect of exogenous H2O2 on normal HPFs with regard to ROS and MAPKs.
Abbreviations:
|
HPF |
human pulmonary fibroblast; |
|
ROS |
reactive oxygen species; |
|
MAPK |
mitogen-activated protein kinase; |
|
MEK |
MAP/ERK kinase; |
|
ERK |
extracellular signal-regulated kinase; |
|
JNK |
c-Jun N-terminal kinase; |
|
MMP (Δψm) |
mitochondrial membrane potential; |
|
MTT |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; |
|
FITC |
fluorescein isothiocyanate; |
|
H2DCFDA |
2′,7′-dichloro dihydrofluorescein diacetate; |
|
DHE |
dihydroethidium; |
|
GSH |
glutathione; |
|
CMFDA |
5-chloromethylfluorescein diacetate; |
|
NAC |
N-acetyl cysteine; |
|
PG |
propyl gallate |
Acknowledgements
The present study was supported by a grant from the Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Diabetes Research Center at Chonbuk National University (2012-0009323).
References
|
Gonzalez C, Sanz-Alfayate G, Agapito MT, Gomez-Niño A, Rocher A and Obeso A: Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir Physiol Neurobiol. 132:17–41. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Baran CP, Zeigler MM, Tridandapani S and Marsh CB: The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des. 10:855–866. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 1757:509–517. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zelko IN, Mariani TJ and Folz RJ: Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 33:337–349. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wilcox CS: Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep. 4:160–166. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chen TJ, Jeng JY, Lin CW, Wu CY and Chen YC: Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology. 223:113–126. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Dasmahapatra G, Rahmani M, Dent P and Grant S: The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood. 107:232–240. 2006. View Article : Google Scholar | |
|
Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A and Breuer R: Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol. 290:L790–L796. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Genestra M: Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 19:1807–1819. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Blenis J: Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA. 90:5889–5892. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Kusuhara M, Takahashi E, Peterson TE, Abe J, Ishida M, Han J, Ulevitch R and Berk BC: p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res. 83:824–831. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Hsin YH, Chen CF, Huang S, Shih TS, Lai PS and Chueh PJ: The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 179:130–139. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Mao X, Yu CR, Li WH and Li WX: Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res. 18:879–888. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Guyton KZ, Liu Y, Gorospe M, Xu Q and Holbrook NJ: Activation of mitogen-activated protein kinase by H2O2Role in cell survival following oxidant injury. J Biol Chem. 271:4138–4142. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Henson ES and Gibson SB: Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 18:2089–2097. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Park WH: Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells. Hum Exp Toxicol. 30:1945–1954. 2011. View Article : Google Scholar | |
|
Park WH: MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells. Oncol Rep. 27:1611–1618. 2012.PubMed/NCBI | |
|
Perez-Vizcaino F, Cogolludo A and Moreno L: Reactive oxygen species signaling in pulmonary vascular smooth muscle. Respir Physiol Neurobiol. 174:212–220. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu TW, Fung KP, Zeng LH, Wu J and Nakamura H: Propyl gallate as a hepatoprotector in vitro and in vivo. Biochem Pharmacol. 48:419–422. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi H, Oikawa S, Hirakawa K and Kawanishi S: Metal-mediated oxidative damage to cellular and isolated DNA by gallic acid, a metabolite of antioxidant propyl gallate. Mutat Res. 558:111–120. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kawanishi S, Oikawa S and Murata M: Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal. 7:1728–1739. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jacobi H, Eicke B and Witte I: DNA strand break induction and enhanced cytotoxicity of propyl gallate in the presence of copper(II). Free Radic Biol Med. 24:972–978. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Nakagawa Y, Nakajima K, Tayama S and Moldéus P: Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor. Mol Pharmacol. 47:1021–1027. 1995.PubMed/NCBI | |
|
Han YH and Park WH: Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level. Food Chem Toxicol. 47:2531–2538. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Reddan JR, Giblin FJ, Sevilla M, Padgaonkar V, Dziedzic DC, Leverenz VR, Misra IC, Chang JS and Pena JT: Propyl gallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H2O2 insult. Exp Eye Res. 76:49–59. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chen CH, Liu TZ, Chen CH, Wong CH, Chen CH, Lu FJ and Chen SC: The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Mol Nutr Food Res. 51:962–968. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rhee SG, Yang KS, Kang SW, Woo HA and Chang TS: Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal. 7:619–626. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Estrela JM, Ortega A and Obrador E: Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 43:143–181. 2006. View Article : Google Scholar | |
|
Higuchi Y: Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med. 8:455–464. 2004. View Article : Google Scholar : PubMed/NCBI |
